Close Menu

NEW YORK – BioMérieux reported on Tuesday that its third quarter revenues grew 13 percent year over year.

For the three months ended Sept. 30, the Marcy l'Étoile, France-based in vitro diagnostics firm recorded revenues of €653.1 million ($727.2 million) compared to €579.3 million in the year-ago period. Organic growth, at constant exchange rates and scope of consolidation, was approximately 10 percent year over year.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.